SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-04-211198
Filing Date
2004-12-10
Accepted
2004-12-10 17:07:03
Documents
6
Period of Report
2004-12-10
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 25911
2 CERTIFICATE OF AMENDMENT OF AMENDED AND RESTATED CERTIFICATE dex31.htm EX-3.1 7052
3 CONTINGENT VALUE RIGHTS AGREEMENT dex103.htm EX-10.3 271453
4 PRESS RELEASE dex991.htm EX-99.1 19528
5 GRAPHIC g4263342633image002.jpg GRAPHIC 18361
6 GRAPHIC g4263342633image004.jpg GRAPHIC 9297
  Complete submission text file 0001193125-04-211198.txt   354092
Mailing Address 345 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 345 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650.635.1100
VIROLOGIC INC (Filer) CIK: 0001094961 (see all company filings)

IRS No.: 943234479 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30369 | Film No.: 041197065
SIC: 2835 In Vitro & In Vivo Diagnostic Substances